Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | NRG2 | Human | 1,2-dichloroethane | decreases expression | ISO | Nrg2 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of NRG2 mRNA | CTD | PMID:28960355 | NRG2 | Human | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NRG2 mRNA | CTD | PMID:23373633 | NRG2 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NRG2 mRNA | CTD | PMID:33387578 | NRG2 | Human | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | NRG2 | Human | 2,4,6-trinitrotoluene | affects expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Trinitrotoluene affects the expression of NRG2 mRNA | CTD | PMID:21346803 | NRG2 | Human | 4,4'-sulfonyldiphenol | affects methylation | ISO | Nrg2 (Mus musculus) | 6480464 | bisphenol S affects the methylation of NRG2 gene | CTD | PMID:31683443 | NRG2 | Human | 6-propyl-2-thiouracil | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Propylthiouracil results in decreased expression of NRG2 mRNA | CTD | PMID:24780913 | NRG2 | Human | acrylamide | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Acrylamide results in decreased expression of NRG2 mRNA | CTD | PMID:28959563 | NRG2 | Human | aflatoxin B1 | decreases methylation | EXP | | 6480464 | Aflatoxin B1 results in decreased methylation of NRG2 intron | CTD | PMID:30157460 | NRG2 | Human | alpha-Zearalanol | multiple interactions | ISO | Nrg2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of NRG2 mRNA and [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NRG2 mRNA | CTD | PMID:35163327 | NRG2 | Human | ammonium chloride | affects expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Ammonium Chloride affects the expression of NRG2 mRNA | CTD | PMID:16483693 | NRG2 | Human | arsane | affects expression | EXP | | 6480464 | Arsenic affects the expression of NRG2 protein | CTD | PMID:24675094 | NRG2 | Human | arsenic atom | affects expression | EXP | | 6480464 | Arsenic affects the expression of NRG2 protein | CTD | PMID:24675094 | NRG2 | Human | asbestos | affects methylation | EXP | | 6480464 | Asbestos affects the methylation of NRG2 gene | CTD | PMID:28722770 | NRG2 | Human | benzalkonium chloride | multiple interactions | ISO | Nrg2 (Mus musculus) | 6480464 | [IL6 protein affects the susceptibility to Benzalkonium Compounds] which affects the expression of NRG2 mRNA | CTD | PMID:30171875 | NRG2 | Human | benzo[a]pyrene | increases methylation | EXP | | 6480464 | Benzo(a)pyrene results in increased methylation of NRG2 promoter | CTD | PMID:27901495 | NRG2 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of NRG2 intron | CTD | PMID:30157460 | NRG2 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of NRG2 3' UTR | CTD | PMID:27901495 | NRG2 | Human | benzo[e]pyrene | increases methylation | EXP | | 6480464 | benzo(e)pyrene results in increased methylation of NRG2 intron | CTD | PMID:30157460 | NRG2 | Human | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of NRG2 mRNA | CTD | PMID:31163220 | NRG2 | Human | bisphenol A | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of NRG2 mRNA | CTD | PMID:25181051 | NRG2 | Human | bisphenol A | increases expression | ISO | Nrg2 (Mus musculus) | 6480464 | bisphenol A results in increased expression of NRG2 mRNA | CTD | PMID:32156529 | NRG2 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of NRG2 gene | CTD | PMID:31601247 | NRG2 | Human | bisphenol A | affects methylation | EXP | | 6480464 | bisphenol A affects the methylation of NRG2 gene | CTD | PMID:31601247 | NRG2 | Human | bisphenol A | increases methylation | ISO | Nrg2 (Rattus norvegicus) | 6480464 | bisphenol A results in increased methylation of NRG2 gene | CTD | PMID:28505145 | NRG2 | Human | C60 fullerene | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | fullerene C60 results in decreased expression of NRG2 mRNA | CTD | PMID:19167457 | NRG2 | Human | calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of NRG2 mRNA | CTD | PMID:16002434 | NRG2 | Human | carbon nanotube | decreases expression | ISO | Nrg2 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | NRG2 | Human | copper atom | multiple interactions | ISO | Nrg2 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of NRG2 mRNA | CTD | PMID:26033743 | NRG2 | Human | copper atom | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Copper results in decreased expression of NRG2 mRNA | CTD | PMID:30556269 | NRG2 | Human | copper atom | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of NRG2 mRNA | CTD | PMID:26033743 | NRG2 | Human | copper(0) | multiple interactions | ISO | Nrg2 (Rattus norvegicus) | 6480464 | [Copper co-treated with Dietary Sucrose] results in increased expression of NRG2 mRNA | CTD | PMID:26033743 | NRG2 | Human | copper(0) | decreases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Copper results in decreased expression of NRG2 mRNA | CTD | PMID:30556269 | NRG2 | Human | copper(0) | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Copper deficiency results in increased expression of NRG2 mRNA | CTD | PMID:26033743 | NRG2 | Human | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of NRG2 mRNA | CTD | PMID:20106945 | NRG2 | Human | decabromodiphenyl ether | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | decabromobiphenyl ether results in increased expression of NRG2 mRNA | CTD | PMID:23914054 | NRG2 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | NRG2 | Human | epoxiconazole | increases expression | ISO | Nrg2 (Mus musculus) | 6480464 | epoxiconazole results in increased expression of NRG2 mRNA | CTD | PMID:35436446 | NRG2 | Human | fenvalerate | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | fenvalerate results in increased expression of NRG2 mRNA | CTD | PMID:30307764 | NRG2 | Human | fipronil | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | fipronil results in increased expression of NRG2 mRNA | CTD | PMID:31881178 | NRG2 | Human | fonofos | increases methylation | EXP | | 6480464 | Fonofos results in increased methylation of NRG2 promoter | CTD | PMID:22847954 | NRG2 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of NRG2 gene | CTD | PMID:31601247 | NRG2 | Human | fulvestrant | increases methylation | EXP | | 6480464 | Fulvestrant results in increased methylation of NRG2 gene | CTD | PMID:31601247 | NRG2 | Human | lipopolysaccharide | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NRG2 mRNA] | CTD | PMID:35811015 | NRG2 | Human | lipopolysaccharide | increases expression | EXP | | 6480464 | Lipopolysaccharides results in increased expression of NRG2 mRNA | CTD | PMID:35811015 | NRG2 | Human | manganese atom | increases expression | EXP | | 6480464 | Manganese results in increased expression of NRG2 mRNA | CTD | PMID:17175027 | NRG2 | Human | manganese(0) | increases expression | EXP | | 6480464 | Manganese results in increased expression of NRG2 mRNA | CTD | PMID:17175027 | NRG2 | Human | manganese(II) chloride | increases expression | EXP | | 6480464 | manganese chloride results in increased expression of NRG2 mRNA | CTD | PMID:17175027 | NRG2 | Human | melphalan | decreases expression | EXP | | 6480464 | Melphalan results in decreased expression of NRG2 mRNA | CTD | PMID:22363485 | NRG2 | Human | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of NRG2 mRNA | CTD | PMID:28001369 | NRG2 | Human | N,N-diethyl-m-toluamide | multiple interactions | ISO | Nrg2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] affects the methylation of NRG2 gene | CTD | PMID:33148267 | NRG2 | Human | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of NRG2 mRNA | CTD | PMID:24768652 and PMID:25583101 | NRG2 | Human | ozone | multiple interactions | ISO | Nrg2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of NRG2 mRNA | CTD | PMID:34911549 | NRG2 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NRG2 mRNA | CTD | PMID:22230336 and PMID:29067470 | NRG2 | Human | paracetamol | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of NRG2 mRNA | CTD | PMID:33387578 | NRG2 | Human | parathion | increases methylation | EXP | | 6480464 | Parathion results in increased methylation of NRG2 promoter | CTD | PMID:22847954 | NRG2 | Human | perfluorooctanoic acid | multiple interactions | ISO | Nrg2 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of NRG2 mRNA and [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NRG2 mRNA | CTD | PMID:35163327 | NRG2 | Human | permethrin | multiple interactions | ISO | Nrg2 (Rattus norvegicus) | 6480464 | [Permethrin co-treated with DEET] affects the methylation of NRG2 gene | CTD | PMID:33148267 | NRG2 | Human | pirinixic acid | multiple interactions | ISO | Nrg2 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of NRG2 mRNA | CTD | PMID:19710929 | NRG2 | Human | potassium dichromate | decreases expression | ISO | Nrg2 (Mus musculus) | 6480464 | Potassium Dichromate results in decreased expression of NRG2 mRNA | CTD | PMID:23608068 | NRG2 | Human | raloxifene | increases expression | EXP | | 6480464 | Raloxifene Hydrochloride results in increased expression of NRG2 mRNA | CTD | PMID:15849065 | NRG2 | Human | resveratrol | multiple interactions | EXP | | 6480464 | [Plant Extracts co-treated with Resveratrol] results in decreased expression of NRG2 mRNA | CTD | PMID:23557933 | NRG2 | Human | S-(1,2-dichlorovinyl)-L-cysteine | multiple interactions | EXP | | 6480464 | S-(1 and 2-dichlorovinyl)cysteine inhibits the reaction [Lipopolysaccharides results in increased expression of NRG2 mRNA] | CTD | PMID:35811015 | NRG2 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... | CTD | PMID:27188386 | NRG2 | Human | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of NRG2 mRNA | CTD | PMID:34973136 | NRG2 | Human | sodium arsenite | decreases expression | EXP | | 6480464 | sodium arsenite results in decreased expression of NRG2 mRNA | CTD | PMID:34032870 | NRG2 | Human | sodium arsenite | increases expression | ISO | Nrg2 (Mus musculus) | 6480464 | sodium arsenite results in increased expression of NRG2 mRNA | CTD | PMID:37682722 | NRG2 | Human | terbufos | increases methylation | EXP | | 6480464 | terbufos results in increased methylation of NRG2 promoter | CTD | PMID:22847954 | NRG2 | Human | titanium dioxide | decreases methylation | ISO | Nrg2 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of NRG2 gene and titanium dioxide results in decreased methylation of NRG2 promoter | CTD | PMID:35295148 | NRG2 | Human | titanium dioxide | increases methylation | ISO | Nrg2 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of NRG2 gene | CTD | PMID:35295148 | NRG2 | Human | titanium dioxide | increases expression | ISO | Nrg2 (Mus musculus) | 6480464 | titanium dioxide results in increased expression of NRG2 mRNA | CTD | PMID:35295148 | NRG2 | Human | trichloroethene | increases expression | ISO | Nrg2 (Rattus norvegicus) | 6480464 | Trichloroethylene results in increased expression of NRG2 mRNA | CTD | PMID:33387578 | NRG2 | Human | triclosan | decreases expression | EXP | | 6480464 | Triclosan results in decreased expression of NRG2 mRNA | CTD | PMID:30510588 | NRG2 | Human | triptonide | decreases expression | ISO | Nrg2 (Mus musculus) | 6480464 | triptonide results in decreased expression of NRG2 mRNA | CTD | PMID:33045310 | NRG2 | Human | valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of NRG2 mRNA | CTD | PMID:25979313 | NRG2 | Human | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of NRG2 mRNA | CTD | PMID:26272509 | NRG2 | Human | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NRG2 mRNA | CTD | PMID:27188386 | NRG2 | Human | vorinostat | increases expression | EXP | | 6480464 | vorinostat results in increased expression of NRG2 mRNA | CTD | PMID:26272509 | NRG2 | Human | vorinostat | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NRG2 mRNA | CTD | PMID:27188386 | |